Skip to main content

and
  1. Article

    Open Access

    A mechanistic mathematical model of initiation and malignant transformation in sporadic vestibular schwannoma

    A vestibular schwannoma (VS) is a relatively rare, benign tumour of the eighth cranial nerve, often involving alterations to the gene NF2. Previous mathematical models of schwannoma incidence have not attempted t...

    Chay Paterson, Ivana Bozic, Miriam J. Smith, Xanthe Hoad in British Journal of Cancer (2022)

  2. No Access

    Article

    BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?

    National guidelines recommend testing all cases of non-mucinous epithelial ovarian cancer (NMEOC) for germline (blood) and somatic (tumour) BRCA1/2 pathogenic variants (PVs). We performed paired germline and soma...

    Robert D. Morgan, George J. Burghel, Nicola Flaum in British Journal of Cancer (2022)

  3. Article

    Open Access

    Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants

    To improve breast cancer risk stratification to enable more targeted early detection/prevention strategies that will better balance risks and benefits of population screening programmes.

    D. Gareth R. Evans, Elaine F. Harkness in Breast Cancer Research and Treatment (2019)

  4. Article

    Open Access

    PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

    Poly(ADP-ribose) polymerase inhibitors (PARPi) have changed the management of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi was based on the concept of synthetic lethalit...

    Robert D. Morgan, Andrew R. Clamp in Cancer Chemotherapy and Pharmacology (2018)

  5. Article

    Open Access

    Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds

    In kindreds carrying path_BRCA1/2 variants, some women in these families will develop cancer despite testing negative for the family’s pathogenic variant. These families may have additional genetic variants, whic...

    Mev Dominguez-Valentin, D. Gareth R. Evans in Hereditary Cancer in Clinical Practice (2018)

  6. Article

    Open Access

    Intermittent energy restriction induces changes in breast gene expression and systemic metabolism

    Observational studies suggest weight loss and energy restriction reduce breast cancer risk. Intermittent energy restriction (IER) reduces weight to the same extent as, or more than equivalent continuous energy...

    Michelle N. Harvie, Andrew H. Sims, Mary Pegington in Breast Cancer Research (2016)

  7. Article

    Open Access

    Breast cancer risk feedback to women in the UK NHS breast screening population

    There are widespread moves to develop risk-stratified approaches to population-based breast screening. The public needs to favour receiving breast cancer risk information, which ideally should produce no detri...

    D Gareth R Evans, Louise S Donnelly, Elaine F Harkness in British Journal of Cancer (2016)

  8. Article

    Open Access

    Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort

    The Predicting Risk of Cancer at Screening study in Manchester, UK, is a prospective study of breast cancer risk estimation. It was designed to assess whether mammographic density may help in refinement of bre...

    Adam R. Brentnall, Elaine F. Harkness, Susan M. Astley in Breast Cancer Research (2015)

  9. Article

    Open Access

    The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services

    It is frequent for news items to lead to a short lived temporary increase in interest in a particular health related service, however it is rare for this to have a long lasting effect. In 2013, in the UK in pa...

    D Gareth R Evans, Julian Barwell, Diana M Eccles, Amanda Collins in Breast Cancer Research (2014)

  10. No Access

    Chapter

    Cranial Meningioma in Neurofibromatosis Type 2 Patients: Role of Mutations

    Meningiomas are the most common form of primary intracranial tumour in adults and are associated with the neurogenetic syndrome neurofibromatosis type 2 (NF2). Somatic mutations of the NF2 gene are found in the m...

    Miriam J. Smith, D. Gareth R. Evans in Tumors of the Central Nervous System, Volume 11 (2014)

  11. No Access

    Article

    Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral

    The aim of this study was to establish if risk-reducing surgery (RRS) increases survival among BRCA1/2 carriers without breast/ovarian cancer at the time of family referral. Female BRCA1/2 carriers were identifie...

    Sarah L. Ingham, Matthew Sperrin, Andrew Baildam in Breast Cancer Research and Treatment (2013)

  12. No Access

    Article

    Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

    BRCA1/2 mutation carriers with breast cancer are at high risk of contralateral disease. Such women often elect to have contralateral risk-reducing mastectomy (CRRM) to reduce the likelihood of re...

    D. Gareth R. Evans, Sarah L. Ingham, Andrew Baildam in Breast Cancer Research and Treatment (2013)

  13. Article

    Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives

    D Gareth R Evans, Anthony Howell, Sarah L Ingham, Iain Buchan in Breast Cancer Research (2013)

  14. Article

    Open Access

    Malignant peripheral nerve sheath tumours in inherited disease

    Malignant peripheral nerve sheath tumours (MPNST) are rare tumours known to occur at high frequency in neurofibromatosis 1 (NF1), but may also occur in other cancer prone syndromes.

    D Gareth R Evans, Susan M Huson, Jillian M Birch in Clinical Sarcoma Research (2012)

  15. No Access

    Article

    High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?

    Miriam J. Smith, Franchesca L. Gifford in Breast Cancer Research and Treatment (2012)

  16. Article

    Breast cancer risk-assessment models

    There are two main questions when assessing a woman for interventions to reduce her risks of develo** or dying from breast cancer, the answers of which will determine her access: What are her chances of carr...

    D Gareth R Evans, Anthony Howell in Breast Cancer Research (2007)

  17. No Access

    Article

    Mechanisms of Disease: prediction and prevention of breast cancer—cellular and molecular interactions

    Breast cancer is a multifactorial condition, and changes in cellular biology are affected by a large number of variables known to affect an individual's susceptibility to this malignancy. Current risk predicti...

    Anthony Howell, Andrew H Sims, Kai Ren Ong in Nature Clinical Practice Oncology (2005)

  18. No Access

    Article

    Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer

    The molecular basis for most non-HNPCC familial colorectal cancer cases is unknown, but there is increasing evidence that common genetic variants may play a role. We investigated the contribution of polymorphi...

    Timothy R Porter, Frances M Richards, Richard S Houlston, D Gareth R Evans in Oncogene (2002)

  19. No Access

    Article

    Relative frequency and morphology of cancers in carriers of germline TP53 mutations

    The spectrum and frequency of cancers associated with germline TP53 mutations are uncertain. To address this issue a cohort of individuals from 28 families with Li-Fraumeni syndrome, segregating germline TP53 ...

    Jillian M Birch, Robert D Alston, Richard JQ McNally, D Gareth R Evans in Oncogene (2001)

  20. Article

    The pathology of familial breast cancer: Clinical and geneticcounselling implications of breast cancer pathology

    Approximately 5% of all breast cancers are due to one of the high-risk breast cancer genes BRCA1 and BRCA2, or possibly to a third or fourth moderate- to high-risk gene(s). A further proportion of cases arise in ...

    Fiona Lalloo, D Gareth R Evans in Breast Cancer Research (1999)